MX355668B - Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes. - Google Patents
Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes.Info
- Publication number
- MX355668B MX355668B MX2015000276A MX2015000276A MX355668B MX 355668 B MX355668 B MX 355668B MX 2015000276 A MX2015000276 A MX 2015000276A MX 2015000276 A MX2015000276 A MX 2015000276A MX 355668 B MX355668 B MX 355668B
- Authority
- MX
- Mexico
- Prior art keywords
- acnes
- agent against
- myrtle extract
- biofilm agent
- biofilm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a una composición dermatológica que contiene un extracto de mirto a una concentración que es mayor que o igual a 0.01% en peso, para el uso del misma como un agente anti-biopelícula contra Propionibacterium acnes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1256607A FR2992862B1 (fr) | 2012-07-09 | 2012-07-09 | Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes |
PCT/EP2013/064415 WO2014009325A1 (fr) | 2012-07-09 | 2013-07-08 | Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015000276A MX2015000276A (es) | 2015-07-21 |
MX355668B true MX355668B (es) | 2018-04-24 |
Family
ID=47022816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015000276A MX355668B (es) | 2012-07-09 | 2013-07-08 | Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes. |
Country Status (9)
Country | Link |
---|---|
US (1) | US9808496B2 (es) |
EP (1) | EP2869827B1 (es) |
JP (1) | JP2015522054A (es) |
BR (1) | BR112015000275B1 (es) |
CA (1) | CA2878496C (es) |
ES (1) | ES2635382T3 (es) |
FR (1) | FR2992862B1 (es) |
MX (1) | MX355668B (es) |
WO (1) | WO2014009325A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2684150C (en) | 2007-05-14 | 2016-10-04 | Research Foundation Of State University Of New York | Decenoic acid dispersion inducers in the treatment of biofilms |
GB2565511B (en) | 2016-05-26 | 2022-04-13 | Kimberly Clark Co | Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
FR3120790B1 (fr) | 2021-03-10 | 2024-03-15 | Fabre Pierre Dermo Cosmetique | Association d’un extrait de myrte et d’un extrait de Tripterygium wilfordii pour lutter contre l’inflammation induite par C. acnes |
FR3132632A1 (fr) | 2022-02-17 | 2023-08-18 | Pierre Fabre Dermo-Cosmetique | Composition comprenant un extrait de myrte et un extrait de Tripterygium wilfordii pour lutter contre l’acné des zones non lésionnelles de la peau acnéique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2783425B1 (fr) | 1998-09-17 | 2002-06-07 | Fabre Pierre Dermo Cosmetique | Extrait de myrte titre en myrtucommulone b', son procede de preparation et son application en dermatologie et en cosmetologie |
US20060008538A1 (en) * | 2004-07-07 | 2006-01-12 | Wu Jeffrey M | Methods of treating the skin |
WO2012053010A2 (en) * | 2010-10-21 | 2012-04-26 | Cadila Healthcare Limited | Method for treatment of acne using pharmaceutical compositions of clindamycin |
-
2012
- 2012-07-09 FR FR1256607A patent/FR2992862B1/fr active Active
-
2013
- 2013-07-08 CA CA2878496A patent/CA2878496C/fr active Active
- 2013-07-08 MX MX2015000276A patent/MX355668B/es active IP Right Grant
- 2013-07-08 JP JP2015520946A patent/JP2015522054A/ja active Pending
- 2013-07-08 ES ES13737198.5T patent/ES2635382T3/es active Active
- 2013-07-08 US US14/413,436 patent/US9808496B2/en active Active
- 2013-07-08 EP EP13737198.5A patent/EP2869827B1/fr active Active
- 2013-07-08 BR BR112015000275-7A patent/BR112015000275B1/pt active IP Right Grant
- 2013-07-08 WO PCT/EP2013/064415 patent/WO2014009325A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2878496A1 (fr) | 2014-01-16 |
US20150190447A1 (en) | 2015-07-09 |
FR2992862B1 (fr) | 2014-10-03 |
JP2015522054A (ja) | 2015-08-03 |
US9808496B2 (en) | 2017-11-07 |
MX2015000276A (es) | 2015-07-21 |
EP2869827B1 (fr) | 2017-05-03 |
CA2878496C (fr) | 2020-12-15 |
ES2635382T3 (es) | 2017-10-03 |
BR112015000275A2 (pt) | 2017-06-27 |
FR2992862A1 (fr) | 2014-01-10 |
WO2014009325A1 (fr) | 2014-01-16 |
BR112015000275B1 (pt) | 2021-02-09 |
EP2869827A1 (fr) | 2015-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
PH12016501151A1 (en) | Nrf2 regulators | |
MX2015008628A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
MA39727A (fr) | Compositions antimicrobiennes pour végétaux | |
MX2017004838A (es) | Composiciones de interleucina-15 y usos de estas. | |
PH12016500511A1 (en) | Selective grp94 inhibitors and uses thereof | |
MX356368B (es) | Profarmacos de fumaratos y su uso en el tratamiento de diferentes enfermedades. | |
MX2016011898A (es) | Composiciones de compuestos selenoorganicos y metodos de uso de los mismos. | |
PH12018500446A1 (en) | Pyridinone dicarboxamide for use as bromodomain inhibitors | |
NZ712270A (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
PH12017500836A1 (en) | Transdermal formulations | |
IN2014DN11078A (es) | ||
MX355668B (es) | Uso de un extracto de mirto como un agente anti-biopelicula contra propionibacterium acnes. | |
MX362879B (es) | Usos novedosos. | |
MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
BR112014002940A2 (pt) | uso e composição agroquímica de dibutilamidas de ácido carboxílico | |
MX2017008450A (es) | Composiciones inhibidoras de nitrificacion microencapsuladas. | |
MX2018002514A (es) | Citotoxinas modificadas y su uso terapeutico. | |
IN2014DN07326A (es) | ||
MX2016012173A (es) | Inhibidores de las vias de señalizacion de wnt. | |
MX370990B (es) | Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos. | |
MA40027A (fr) | Composition pharmaceutique comprenant un bêta-2 agoniste et un agent anticholinergique | |
MX2016011572A (es) | Composiciones antimicrobianas de acido organico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |